BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25884643)

  • 1. Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study.
    Koelzer VH; Herrmann P; Zlobec I; Karamitopoulou E; Lugli A; Stein U
    BMC Cancer; 2015 Mar; 15():160. PubMed ID: 25884643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers.
    Koelzer VH; Huber B; Mele V; Iezzi G; Trippel M; Karamitopoulou E; Zlobec I; Lugli A
    Hum Pathol; 2015 Nov; 46(11):1573-81. PubMed ID: 26351067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and prognostic significance of metastasis-associated in colon cancer-1 (MACC1) overexpression in colorectal cancer: a meta-analysis.
    Zhao Y; Dai C; Wang M; Kang H; Lin S; Yang P; Liu X; Liu K; Xu P; Zheng Y; Li S; Dai Z
    Oncotarget; 2016 Sep; 7(39):62966-62975. PubMed ID: 27542234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
    Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
    Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
    Lu G; Zhou L; Zhang X; Zhu B; Wu S; Song W; Gong X; Wang D; Tao Y
    World J Surg Oncol; 2016 Oct; 14(1):276. PubMed ID: 27793161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients.
    Ilm K; Kemmner W; Osterland M; Burock S; Koch G; Herrmann P; Schlag PM; Stein U
    Mol Cancer; 2015 Feb; 14():38. PubMed ID: 25742883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases.
    Isella C; Mellano A; Galimi F; Petti C; Capussotti L; De Simone M; Bertotti A; Medico E; Muratore A
    Ann Surg; 2013 Jun; 257(6):1089-95. PubMed ID: 23665971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in Klatskin tumor patients.
    Lederer A; Herrmann P; Seehofer D; Dietel M; Pratschke J; Schlag P; Stein U
    Hepatology; 2015 Sep; 62(3):841-50. PubMed ID: 25953673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased MACC1 levels in tissues and blood identify colon adenoma patients at high risk.
    Ashktorab H; Hermann P; Nouraie M; Shokrani B; Lee E; Haidary T; Brim H; Stein U
    J Transl Med; 2016 Jul; 14(1):215. PubMed ID: 27439755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
    Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
    Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNPs in the coding region of the metastasis-inducing gene MACC1 and clinical outcome in colorectal cancer.
    Schmid F; Burock S; Klockmeier K; Schlag PM; Stein U
    Mol Cancer; 2012 Jul; 11():49. PubMed ID: 22838389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of MACC1 protein in colorectal cancer and its relationship with clinicopathological characteristics].
    Xu L; Xuan Z; Lin G; Qiu H; Xiao Y; Wu B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):1032-5. PubMed ID: 26499151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MACC1 is related to colorectal cancer initiation and early-stage invasive growth.
    Ren B; Zakharov V; Yang Q; McMahon L; Yu J; Cao W
    Am J Clin Pathol; 2013 Nov; 140(5):701-7. PubMed ID: 24124150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer.
    Nitsche U; Rosenberg R; Balmert A; Schuster T; Slotta-Huspenina J; Herrmann P; Bader FG; Friess H; Schlag PM; Stein U; Janssen KP
    Ann Surg; 2012 Nov; 256(5):763-71; discussion 771. PubMed ID: 23095620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
    Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
    Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MACC1 as a marker for advanced colorectal carcinoma.
    Shirahata A; Shinmura K; Kitamura Y; Sakuraba K; Yokomizo K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Hibi K
    Anticancer Res; 2010 Jul; 30(7):2689-92. PubMed ID: 20682999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active immunosurveillance in the tumor microenvironment of colorectal cancer is associated with low frequency tumor budding and improved outcome.
    Koelzer VH; Dawson H; Andersson E; Karamitopoulou E; Masucci GV; Lugli A; Zlobec I
    Transl Res; 2015 Aug; 166(2):207-17. PubMed ID: 25797890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.